Tyrosine Kinase Inhibitors

DBCAT001447Pharmacologic class

Protein kinase inhibitors that inhibit TYROSINE PROTEIN KINASES. A DrugBank category of 94 drugs. 63 of them are approved.

Also known as
Protein Tyrosine Kinase Inhibitor · TKIs · Protein-Tyrosine Kinases, antagonists & inhibitors

What you can answer from here — as of August 07, 2018

94DrugsEach linked to its full drug card
Sign in
355Drug targetsEvery drug–target pair in the class, with bond type
Sign in
3,532Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
4Routes of administrationHow the drugs in this class are given
Sign in
1SubcategoryNarrower classes within this one
Sign in

Which targets do Tyrosine Kinase Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account